PharmaCielo Makes Initial Shipments to two Brazilian Customers
News provided by
Share this article
1 early integration into the supply chain.
Shipments followed an audit by the Phyto-Therapeutics customer, that confirmed PharmaCielo s compliance with Brazilian GMP standards.
TORONTO, and RIONEGRO, Colombia, April 26, 2021 /CNW/ - PharmaCielo Ltd. ( PharmaCielo or the Company ) (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that it has completed initial shipments to two customers in Brazil following an audit to confirm PharmaCielo s compliance with Brazilian Good Manufacturing Practices ( GMP ) standards. The first shipment recently arrived at one of Brazil s largest Phyto-Therapeutics companies. This customer intends to integrate PharmaCielo s APIs into custom formulations for current and future product registry and sale in the local